Lack of association of very low density lipoprotein receptor gene polymorphism with caucasian Alzheimer's disease

Annals of Neurology

Volumn 40, Issue 2, 1996, Pages 251-254

  Okuizumi, Kaoru ^a   Onodera, Osamu ^a,e   Seki, Koji ^a,d   Tanaka, Hajime ^a,c   Namba, Yoshio ^a,b   Ikeda, Kazuhiko ^a   Saunders, Ann M ^a   Pericak Vance, Margaret A ^b   Roses, Allen D ^c   Tsuji, Shoji ^a,d  

^a NIIGATA UNIVERSITY   (Japan)

^b Department of Neurology ^*  (Japan)

^c Mishima Hospital   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPOPROTEIN RECEPTOR; TRINUCLEOTIDE; VERY LOW DENSITY LIPOPROTEIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; FAMILIAL DISEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 9444244971     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400220     Document Type: Article

References (15)

1. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;26l:921-923
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
3. Ueki A, Kawano M, Namba Y, et al. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with lateonset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163: 166-168
4. Okuizumi K, Onodera O, Tanaka H, et al. APOE-E4 and eatly-onset Alzheimer's. Nature Genet 1994;7:10-11
5. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-78
6. Takahashi S, Kawarabayashi Y, Nakai T, et al. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptorlike protein with distinct ligand specificity. Proc Natl Acad Sei USA 1992:89:9252-9256
7. Sakai J, Hoshino A, Takahashi S, et al. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J Biol Chem 1994;269:2173-2182
8. Yamamoto T, Takahashi S, Sakai J, Kawarabayashi Y. The very low density lipoprotein receptor. A second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc Med 1993:3:144-148
9. Jokinen E. Sakai J, Yamamoto T, Hobbs HH. CGG triple repeat polymorphism in VLDL receptor (VLDL-R) gene. Hum Mol Genet 1994:3:521
10. Okuizumi K, Onodera O, Namba Y, et al. Genetic association of very low density lipoprotein (VLDL) receptor gene locus with sporadic Alzheimer's disease. Nature Genet 1995:11:207209
11. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984:34:939-944
12. SAS Technical Report P-200 and P229. Release 6.07. Gary, NC: SAS Institutes, 1992
13. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu Rev Med 1996;47:387-400
14. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE4associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nature Genet 1995:10:486-488
15. Haines JL, Pritchard ML, Saunders AM, et al. No genetic effect of α1-antichymotrypsin in Alzheimer disease. Genomics (In press)